Immunotherapy: Tollys presents new data at OTS 2022, demonstrating anti-tumor activity of TL-532
Covalab, CimCure and partners receive €1.06M EUREKA Eurostars grant to develop new combination therapy for glioblastoma
Tridek-One closes a €16 million financing round to develop first-in-class immune checkpoint agonists
Robocath’s joint venture, Cathbot, concludes first clinical study in China to evaluate robotic PCI safety and efficacy
Diabetes: AdipoPharma’s first-in-class candidate – PATAS – shows improvement in whole-body insulin resistance and associated comorbidities in vivo
ABL partners with KaliVir Immunotherapeutics to advance development of oncolytic viruses
Nosopharm welcomes new members to supervisory board
Thabor Therapeutics secures €2 million in deep tech financing from Bpifrance
